Printer Friendly

ANGEION TO EXPLORE SALE OF MEDICAL PRODUCTS DIVISION

 ANGEION TO EXPLORE SALE OF MEDICAL PRODUCTS DIVISION
 MINNEAPOLIS, March 26 /PRNewswire/ -- Angeion Corporation


(NASDAQ: ANGN) today announced that it has engaged the investment banking firm of Piper, Jaffray & Hopwood Incorporated as its exclusive agent to explore the potential sale of the assets and business of its Angeion Medical Products (AMP) division, and to provide other investment banking services.
 Angeion Medical Products designs, manufactures and markets a variety of proprietary products as well as custom products for other medical companies. These products consist primarily of interventional products including angioplasty accessories, catheters, introducers, adapters, pacing leads, inflation devices and coronary access devices.
 Angeion believes that the sale of the Medical Products division and the strategic redeployment of these assets into its two subsidiaries, AngeLase, Inc. and AngeMed, Inc., could offer significant opportunity. Although the Medical Products division accounts for substantially all of Angeion's current revenue, the company believes further investment in its developmental subsidiaries will enhance long-term shareholder value. In addition to providing funding for AngeLase and AngeMed, this restructuring is consistent with the company's focus on the development of high technology products for treating tachyarrhythmias (rapid, irregular heartbeats). AngeLase is evaluating its nonsurgical laser catheter and mapping technology in clinical trials. AngeMed is developing an automatic implantable defibrillator and external temporary pacemaker.
 -0- 3/26/92
 /CONTACT: Brenda Roth of Angeion, 612-550-9388/
 (ANGN) CO: Angeion Corporation ST: Minnesota IN: MTC SU:


KH -- MN009 -- 2066 03/26/92 15:05 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 26, 1992
Words:240
Previous Article:$125 A DAY PC COULD HAVE PREVENTED SALOMON TRADING ERROR
Next Article:CWA, IBEW TO OPEN CONTRACT TALKS WITH AT&T
Topics:


Related Articles
ANGEION RELEASES FIFTH PRODUCT FAMILY
ANGEION CHAIRMAN AND CEO ISSUES LETTER
ANGEION SIGNS AGREEMENT WITH GERMAN DISTRIBUTOR
ANGEION REPORTS THIRD QUARTER FIGURES
ANGEION SELLS ACCESSORY DIVISION; FOCUSES EXCLUSIVELY ON TREATING ARRHYTHMIAS
ANGEION REPORTS THIRD QUARTER FIGURES
Angeion to Acquire Medical Graphics Corporation.
Angeion Reports Third Quarter Results.
Angeion Completes Acquisition of Medical Graphics Corporation.
Angeion Shareholders Approve Two Transactions; Noteholders Fail to Vote.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters